![Interim Estimates of Vaccine Effectiveness of Pfizer-BioNTech and Moderna COVID-19 Vaccines Among Health Care Personnel — 33 U.S. Sites, January–March 2021 | MMWR Interim Estimates of Vaccine Effectiveness of Pfizer-BioNTech and Moderna COVID-19 Vaccines Among Health Care Personnel — 33 U.S. Sites, January–March 2021 | MMWR](https://www.cdc.gov/mmwr/volumes/70/wr/social-media/mm7020e2_EffectivenessPfizerModernaHCP_IMAGE_14May21_1200x675-medium.jpg?_=36682)
Interim Estimates of Vaccine Effectiveness of Pfizer-BioNTech and Moderna COVID-19 Vaccines Among Health Care Personnel — 33 U.S. Sites, January–March 2021 | MMWR
![Walgreens Tioconazole Ointment 6.5 Percent, 1-Dose Treatment for Vaginal Yeast Infection | Walgreens Walgreens Tioconazole Ointment 6.5 Percent, 1-Dose Treatment for Vaginal Yeast Infection | Walgreens](https://pics.drugstore.com/prodimg/369899/900.jpg)
Walgreens Tioconazole Ointment 6.5 Percent, 1-Dose Treatment for Vaginal Yeast Infection | Walgreens
![Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials - The Lancet Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials - The Lancet](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/db5c63dc-ee49-4b78-b05c-e93ffa8229af/gr1_lrg.jpg)
Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials - The Lancet
![Serological responses and vaccine effectiveness for extended COVID-19 vaccine schedules in England | Nature Communications Serological responses and vaccine effectiveness for extended COVID-19 vaccine schedules in England | Nature Communications](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41467-021-27410-5/MediaObjects/41467_2021_27410_Fig1_HTML.png)
Serological responses and vaccine effectiveness for extended COVID-19 vaccine schedules in England | Nature Communications
![Effectiveness of a fourth dose of mRNA COVID-19 vaccine against all-cause mortality in long-term care facility residents and in the oldest old: A nationwide, retrospective cohort study in Sweden - The Lancet Effectiveness of a fourth dose of mRNA COVID-19 vaccine against all-cause mortality in long-term care facility residents and in the oldest old: A nationwide, retrospective cohort study in Sweden - The Lancet](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/asset/0b6e43e1-5d59-4d2b-aeeb-50247c037446/gr1.jpg)
Effectiveness of a fourth dose of mRNA COVID-19 vaccine against all-cause mortality in long-term care facility residents and in the oldest old: A nationwide, retrospective cohort study in Sweden - The Lancet
![Robust immune responses are observed after one dose of BNT162b2 mRNA vaccine dose in SARS-CoV-2–experienced individuals | Science Translational Medicine Robust immune responses are observed after one dose of BNT162b2 mRNA vaccine dose in SARS-CoV-2–experienced individuals | Science Translational Medicine](https://www.science.org/cms/10.1126/scitranslmed.abi8961/asset/daf68c0c-1d41-4466-bfe3-65e225d105eb/assets/images/large/scitranslmed.abi8961-f1.jpg)
Robust immune responses are observed after one dose of BNT162b2 mRNA vaccine dose in SARS-CoV-2–experienced individuals | Science Translational Medicine
Should FDA Reconsider Allowing the Pooling of COVID-19 Vaccine Doses to Obtain Additional Doses? | Institute For Safe Medication Practices
![Optimizing vaccine allocation for COVID-19 vaccines shows the potential role of single-dose vaccination | Nature Communications Optimizing vaccine allocation for COVID-19 vaccines shows the potential role of single-dose vaccination | Nature Communications](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41467-021-23761-1/MediaObjects/41467_2021_23761_Fig1_HTML.png)
Optimizing vaccine allocation for COVID-19 vaccines shows the potential role of single-dose vaccination | Nature Communications
![Inhibition of Complement Factor 3 in Geographic Atrophy with NGM621: Phase 1 Dose-Escalation Study Results - American Journal of Ophthalmology Inhibition of Complement Factor 3 in Geographic Atrophy with NGM621: Phase 1 Dose-Escalation Study Results - American Journal of Ophthalmology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/522c7a0e-d512-48c0-a799-c432483d9f1b/gr1_lrg.jpg)
Inhibition of Complement Factor 3 in Geographic Atrophy with NGM621: Phase 1 Dose-Escalation Study Results - American Journal of Ophthalmology
![Public health impact of delaying second dose of BNT162b2 or mRNA-1273 covid-19 vaccine: simulation agent based modeling study | The BMJ Public health impact of delaying second dose of BNT162b2 or mRNA-1273 covid-19 vaccine: simulation agent based modeling study | The BMJ](https://www.bmj.com/content/bmj/373/bmj.n1087/F4.medium.jpg)